CXCR4 and leukemia: Therefore, we speculated that FLT3-ITD mutations potentiallyupregulate CXCR4 expression on the surface of leukemia cells and enhance the chemotaxis of AML cells toward CXCL12, consistent with previously reported results14,26,30.